United States Anti-Doping Agency Reauthorization Act
Official title: To reauthorize the United States Anti-Doping Agency, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5614: United States Anti-Doping Agency Reauthorization Act. 113th Congress. Open America. https://openamerica.io/bill/113-HR-5614/
"H.R. 5614: United States Anti-Doping Agency Reauthorization Act." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-HR-5614/.
H.R. 5614, 113th Cong. (2026), https://openamerica.io/bill/113-HR-5614/.
[H.R. 5614: United States Anti-Doping Agency Reauthorization Act](https://openamerica.io/bill/113-HR-5614/)